CHICAGO--(BUSINESS WIRE)--Novian Health, developer of Novilase®Breast Therapy, announced the company has begun a multicenter clinical trial on the use of Novilase® Interstitial Laser Therapy (ILT) for the destruction of malignant breast tumors.
CHICAGO--(BUSINESS WIRE)--Novian Health, developer of Novilase®Breast Therapy, announced the company has begun a multicenter clinical trial on the use of Novilase® Interstitial Laser Therapy (ILT) for the destruction of malignant breast tumors.
